Effects of Low-Doses Aspirin on Clinical Outcome and Disease Progression in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors: Results of a Multicentric Retrospective Study Abstract #1823

Introduction: The chemopreventive effect of aspirin (ASA) have been observed in the setting of colorectal cancer. The impact of aspirin use on clinical outcome of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP NEN) has not been evaluated yet
Aim(s): To retrospectively evaluate the clinical outcome of GEP NEN patients treated with ASA
Materials and methods: All the GEP NENs patients followed up in three European Centres, from January 2005 to September 2016, were retrospectively enrolled. The possible association between ASA and disease grading, staging, primary site, overall OS and PFS were evaluated.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: dr Sara Massironi
Keywords: NEN, ASA

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1042 The Challenge of Differential Diagnosis of Solid Pancreatic Lesions in Von Hippel-Lindau. Case Report
Introduction: Von Hippel-Lindau (VHL) is an hereditary syndrome, characterized by a predisposition to develop benign and malignant tumors. Pancreatic involvement is present in 35-70% of cases and include cystic (simple cyst, serous cystoadenoma, mucinous tumor or IPMN) and solid lesions (neuroendocrine neoplasm (NEN), metastatic mass or pancreatic adenocarcinoma). Finally, a solid-type serous cystoadenoma (SSCA) has been reported. Differential diagnosis of these lesions may be difficult.
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: Alessandra Zilli
#2145 Thrombotic Risk in Gastroenteropancreatic Neuroendocrine Tumors: A Single Centre Experience
Introduction: Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of neoplasms associated with paraneoplastic syndromes. Venous thromboembolism (VTE) is a frequent complication in neoplastic patients and it is associated with increased morbidity and mortality. To date, there have been no specific studies in NEN, except for glucagon-secreting tumors
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: MD Federica Alessandra Cavalcoli
#1656 A Role for Vitamin D in the Gastro-Entero-Pancreatic Neuroendocrine Neoplasms Outcome: Report on a Series from a Single Institute. 
Introduction: Vitamin D deficiency is hypothesized to represent a risk factor in several neoplasms.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Alessandra Zilli
#818 Treatment with Somatostatin Analogs of Recurrent Type I Gastric Carcinoid in Patients with Autoimmune Chronic Atrophic Gastritis
Introduction: The treatment of type 1 gastric carcinoids (GC1) is still debated, in view of their usual benign behavior.
Conference: 11th Annual ENETS Conference (2014)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: PhD Sara Massironi
#1747 Clinical Characterization of Patients with Neuroendocrine Neoplasm of the Appendix in Ireland and in Italy: A Retrospective Study from Two Tertiary Institutions
Introduction: Appendiceal neuroendocrine neoplasms (aNEN) are rare tumors often diagnosed incidentally at appendectomy. Though most aNEN patients have a positive outcome, distant metastases may rarely occur and the identification of the patients at higher risk is required
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: MD Federica Alessandra Cavalcoli